Cross-linking Can Halt the Progression of Keratoconus

23rd October 2013
LaserVision

Corneal collagen cross-linking is a technique that’s been around for a while now but recent studies have now proven that this technique can in fact halt the progression of the disease Keratoconus for up to 5 years.

It is a non-surgical method utilising a UVA light source, which is delivered onto the Cornea, together with a chemical mix largely made up of riboflavin for strengthening the collagen fibres within the corneal structure. The combination of the UVA light and the riboflavin creates a joining or bonding of the chemical structures within the cornea.

The effect is similar to the change we commonly see when toasting bread. A fine slice of bread bends easily and has little strength but after toasting, the bread results in being stronger and slightly more compact.

If you have symptoms of Keratoconus, talk to LaserVision today to see whether Corneal Collagen Cross-linking is right for you.

Related Information

As Seen On

The Guardian Logo
Laser Eye Surgery UK
The Times Laser Eye Surgery
At Home Magazine
Saga Logo
Surrey Advertiser Logo
laser eye surgery london
National Eye Health Week 2014

LaserVision is recognised by the following leading UK private medical insurers

Laser Eye Treatment Allianz
Aviva Logo
Laser Eye Correction Hospital
Bupa Medical Insurers
Eye Correction Treatment
Healix Logo
Vitality Insurers
WPA Healthcare

Professional Associations

Ziemer
Alcon
Schwind
Oculus
Zeiss
BauschLomb
AMO
Physiol
IPCL
STAAR Surgical
Rayner
AcuFocus
HeidelBerg Engineering
HSUK

Professional Bodies

ESCRS
Royal College of Surgeons Edinburgh
Royal College of Ophthalmologists
UKISCRS
ASCRS
ISRS Logo
CareQuality Commission
Request a ConsultationAttend an Event